# Ono Pharma USA Inc clinical trials: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Ono Pharma USA Inc as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ono Pharma USA Inc: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/ono-pharma-usa-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 26, 2013 | NCT01887002 | Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant... | Ono Pharma USA Inc | Phase 2 | Terminated | Irritable Bowel Syndrome (IBS) | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01887002) |
| May 1, 2013 | NCT01844180 | A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel... | Ono Pharma USA Inc | Phase 2 | Completed | Irritable Bowel Syndrome (IBS) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01844180) |
| February 13, 2013 | NCT01790607 | An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment | Ono Pharma USA Inc | Phase 1 | Completed | Hepatic Impairment, Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01790607) |
| August 22, 2012 | NCT01670266 | Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle... | Ono Pharma USA Inc | Phase 1 | Completed | Ocular Hypertension (OHT), Mild Open Angle-glaucoma (OAG) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01670266) |
| June 7, 2012 | NCT01613703 | ONO-2952 Single-dose PET Study in Healthy Adult Subjects | Ono Pharma USA Inc | Phase 1 | Completed | Healthy Adult Subjects | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01613703) |
| March 12, 2012 | NCT01551147 | A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma | Ono Pharma USA Inc | Phase 2 | Completed | Asthma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01551147) |
| February 20, 2012 | NCT01536041 | A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients | Ono Pharma USA Inc | Phase 2 | Completed | Asthma | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01536041) |
| January 12, 2012 | NCT01508988 | Single Dose Escalation Study of ONO-9054 in Healthy Volunteers | Ono Pharma USA Inc | Phase 1 | Completed | Healthy Adult Subjects | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01508988) |
| December 9, 2011 | NCT01489345 | Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects | Ono Pharma USA Inc | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01489345) |
| July 29, 2011 | NCT01405651 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects | Ono Pharma USA Inc | Phase 1 | Completed | Healthy Adult Subjects | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01405651) |
| June 2, 2011 | NCT01364441 | Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects | Ono Pharma USA Inc | Phase 1 | Completed | Healthy Adult Subjects | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01364441) |
| April 29, 2011 | NCT01345214 | A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia | Ono Pharma USA Inc | Phase 1 | Terminated | Chemotherapy-Induced Thrombocytopenia | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01345214) |
| February 17, 2011 | NCT01297582 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects | Ono Pharma USA Inc | Phase 1 | Completed | Healthy Adult Subjects | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01297582) |
| March 5, 2010 | NCT01081782 | A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis | Ono Pharma USA Inc | Phase 2 | Completed | Multiple Sclerosis | 407 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01081782) |
| September 20, 2007 | NCT00532337 | Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis | Ono Pharma USA Inc | Phase 2 | Completed | Osteoporosis, Osteopenia | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00532337) |
| August 10, 2007 | NCT00514865 | Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder | Ono Pharma USA Inc | Phase 2 | Completed | Major Depressive Disorder | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00514865) |
| June 12, 2006 | NCT00335712 | Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus | Ono Pharma USA Inc | Phase 2 | Completed | Type 2 Diabetes Mellitus | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00335712) |
| September 21, 2005 | NCT00212680 | Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan | Ono Pharma USA Inc | Phase 2 | Completed | Postoperative Supraventricular Tachyarrythmia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00212680) |
| September 21, 2005 | NCT00212641 | A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus | Ono Pharma USA Inc | Phase 2 | Completed | Diabetes Mellitus, Type 2 | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00212641) |
| June 18, 2004 | NCT00083421 | Effects of ONO-2506PO in Patients With Alzheimer's Disease | Ono Pharma USA Inc | Phase 2 | Completed | Alzheimer's Disease | 647 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00083421) |
| October 4, 2002 | NCT00046761 | A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke | Ono Pharma USA Inc | Phase 2/3 | Terminated | Cerebrovascular Accident | 1,320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00046761) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 9 |
| Phase 2 | 11 |
| Phase 2/3 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 18 |
| Terminated | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Asthma | 2 |
| Irritable Bowel Syndrome | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Alzheimer Disease | 1 |
| Stroke | 1 |
| Ischemic Stroke | 1 |
| Ocular Hypertension | 1 |
| Glaucoma, Open-Angle | 1 |
| Glaucoma | 1 |
| Eye Diseases | 1 |
| Thrombocytopenia | 1 |
| Multiple Sclerosis | 1 |
| Osteoporosis | 1 |
| Bone Diseases, Metabolic | 1 |
| Depressive Disorder, Major | 1 |
| Coitus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Boat and ship manufacturers in the United States](https://specstream.ai/data/businesses/boat-and-ship-manufacturers/united-states)
- [Doner kebab restaurants in the United States](https://specstream.ai/data/businesses/doner-kebab-restaurants/united-states)
- [Hardware and fastener manufacturers in the United States](https://specstream.ai/data/businesses/hardware-and-fastener-manufacturers/united-states)
- [Medical billing companies in the United States](https://specstream.ai/data/businesses/medical-billing-companies/united-states)
- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
- [Tex-Mex restaurants in the United States](https://specstream.ai/data/businesses/tex-mex-restaurants/united-states)
